Publicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (17)

2023

  1. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL

    Blood, Vol. 141, Núm. 18, pp. 2194-2205

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Replication and single-cycle delivery of SARS-CoV-2 replicons

    Science, Vol. 374, Núm. 6571, pp. 1099-1106

2020

  1. Epigenetic reprogramming sensitizes immunologically silent EBV1 lymphomas to virus-directed immunotherapy

    Blood, Vol. 135, Núm. 21, pp. 1870-1881

  2. Substrate interaction inhibits γ-secretase production of amyloid-β peptides

    Chemical Communications, Vol. 56, Núm. 17, pp. 2578-2581

2019

  1. Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL

    Nature Communications, Vol. 10, Núm. 1

  2. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia

    Nature, Vol. 569, Núm. 7757, pp. 576-580

  3. Somatic mutations and cell identity linked by Genotyping of Transcriptomes

    Nature, Vol. 571, Núm. 7765, pp. 355-360

2018

  1. Integrative structure and functional anatomy of a nuclear pore complex

    Nature, Vol. 555, Núm. 7697, pp. 475-482

2017

  1. Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers

    Cancer Discovery, Vol. 7, Núm. 8, pp. 868-883

2012

  1. Topology-induced inverse phase transitions

    EPL, Vol. 98, Núm. 4

2011

  1. Structure of γ-secretase and its trimeric pre-activation intermediate by single-particle electron microscopy

    Journal of Biological Chemistry, Vol. 286, Núm. 24, pp. 21440-21449

2008

  1. Soluble oligomers of the intramembrane serine protease YqgP are catalytically active in the absence of detergents

    Biochemistry, Vol. 47, Núm. 46, pp. 11920-11929

2007

  1. Sphingolipids and cell death

    Apoptosis, Vol. 12, Núm. 5, pp. 923-939

2003

  1. Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes

    Journal of Biological Chemistry, Vol. 278, Núm. 39, pp. 37169-37174

2002

  1. Role of sphingomyelinase and ceramide in modulating rafts: Do biophysical properties determine biologic outcome?

    FEBS Letters

2000

  1. Compartmentalization of Ceramide Signaling: Physical Foundations and Biological Effects

    Journal of Cellular Physiology, Vol. 184, Núm. 3, pp. 285-300